It’s been a rough few months with the virus.
Fortunately, we’re beginning to see a drop in cases—at least in the U.S. However, that doesn’t mean it won’t pop up again. It also doesn’t mean we can just stop with the testing all of a sudden. In fact, testing will probably stick around for quite some time. According to McKnight’s Long-Term Care News, “Vaccines do not provide 100% protection against the virus, and in rare cases, people who are fully vaccinated may still develop the disease. Those so-called breakthrough cases may be driven by rapid virus changes, and ongoing testing of immunized individuals will be necessary to help prevent future outbreaks, researchers say.”
That’s a big catalyst for companies such as Datametrex AI Limited (TSXV:DM)(OTC:DTMXF), Laboratory Corp. of America Holdings (NYSE:LH), Abbott Laboratories (NYSE:ABT), Quest Diagnostics Inc. (NYSE:DGX), and Chembio Diagnostics Inc. (NASDAQ:CEMI).
The U.S. CDC isn’t even sure how long vaccines will protect people. As they noted, “Although vaccines are effective at keeping you from getting sick, scientists are still learning how well vaccines prevent you from spreading the virus that causes it to others, even if you do not have symptoms. Early data show that vaccines help keep people with no symptoms from spreading it, but we are learning more as more people get vaccinated. We’re also still learning how long vaccines protect people.”